18 results
424B3
CHRO
Chromocell Therapeutics Corp.
16 Apr 24
Prospectus supplement
5:49pm
, shortages of raw materials or failure of any of our key suppliers to deliver necessary components could result in delays in our clinical development … yields and costs.
Any contamination in our manufacturing process, shortages of raw materials or failure of any of our key suppliers to deliver necessary
424B3
CHRO
Chromocell Therapeutics Corp.
16 Apr 24
Prospectus supplement
5:45pm
, shortages of raw materials or failure of any of our key suppliers to deliver necessary components could result in delays in our clinical development … yields and costs.
Any contamination in our manufacturing process, shortages of raw materials or failure of any of our key suppliers to deliver necessary
10-K
2023 FY
CHRO
Chromocell Therapeutics Corp.
16 Apr 24
Annual report
4:48pm
of raw materials or failure of any of our key suppliers to deliver necessary components could result in delays in our clinical development or marketing … and costs.
Any contamination in our manufacturing process, shortages of raw materials or failure of any of our key suppliers to deliver necessary
424B4
CHRO
Chromocell Therapeutics Corp.
20 Feb 24
Prospectus supplement with pricing info
5:30pm
to produce CC8464 on schedule and could, therefore, harm our results of operations and cause reputational damage.
Some of the raw materials required … in our manufacturing process may be derived from biologic sources. Such raw materials are difficult to procure and may be subject to contamination
424B4
CHRO
Chromocell Therapeutics Corp.
20 Feb 24
Prospectus supplement with pricing info
5:28pm
in our manufacturing process, shortages of raw materials or failure of any of our key suppliers to deliver necessary components could result … reputational damage.
Some of the raw materials required in our manufacturing process may be derived from biologic sources. Such raw materials
DRS/A
t97705u
17 Oct 22
Draft registration statement (amended)
12:00am
- Prev
- 1
- Next